Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Investor day

<< Previous

Bullboard Posts

Next >>

Post by jeffm34on Apr 27, 2021 5:40pm

122 Views

Post# 33079251

Investor day

If a company like Suncor can do this, surely it's not beneath TH to do the same.

Suncor will host an Investor Day online at 8:00 a.m. MT (10:00 a.m. ET) on May 26, 2021. Participants will need access to the internet for the full duration of the meeting. The event will consist of two hours of presentations, followed by a one-hour question and answer period

<< Previous

Bullboard Posts

Next >>

Anaergia expands relationship with PepsiCo